Gene transfer of transforming growth factor-β1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity

Human Gene Therapy

Volumn 7, Issue 16, 1996, Pages 1981-1988

  Qin, Lihui ^a   Ding, Yaozhong ^a   Bromberg, Jonathan S ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE TRANSFER; GRAFT SURVIVAL; HEART GRAFT; HELPER CELL; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PLASMID; PROMOTER REGION; RECOMBINANT GENE; SIMIAN VIRUS 40; T LYMPHOCYTE ACTIVATION;

ANIMALIA; MURINAE; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0029844582     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.16-1981     Document Type: Article

References (33)

1. BAKER, P.E., GILLIS, S., and SMITH, K.A. (1979). Monoclonal cytolytic T-cell lines. J. Exp. Med. 149, 273-278.
2. BISHOP, D.K., and OROSZ, C.G. (1989). Limiting dilution analysis for alloreactive, TCGF-secretory T cells. Transplantation 47, 671-677.
3. BROMBERG, J.S. (1995). IL-10 immunosuppression in transplantation. Curr. Opin. Immunol. 7, 639-643.
4. CAREL, J.C., SCHREIBER, R.D., FALQUI, L., and LACY, P.E. (1990). Transforming growth factor beta decreases the immunogenicity of rat islet xenografts (rat to mouse) and prevents rejection in association with treatment of the recipient with a monoclonal antibody to interferon gamma. Proc. Natl. Acad. Sci. USA 87, 1591-1595.
5. DALLMAN, M.J. (1995). Cytokines and transplantation: Th1/Th2 regulation of the immune response to solid organ transplantation in the adult. Curr. Opin. Immunol. 7, 632-638.
6. DERYNCK, R., JARRETT, J.A., CHEN, E.Y., EATON, D.H., BELL, J.R., ASSOIAN, R.K., ROBERTS, A.B., SPORN, M.B., and GOEDDEL, D.V. (1985). Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316, 701-705.
7. ESPEVIK, T., FIGARI, I.S., SHALABY, M.R., LACKIDES, G.A., LEWIS, G.D., SHEPARD, H.M., and PALLADINO, M., JR. (1987). Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J. Exp. Med. 166, 571-576.
8. FONTANA, A., FREI, K., BODMER, S., HOFER, E., SCHREIER, M.H., PALLADINO, M., JR, and ZINKERNAGEL, R.M. (1989). Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice. J. Immunol. 143, 3230-3234.
9. GILL, R.G. (1991). Transforming growth factor beta prevents islet allograft rejection. Transplant. Proc. 23, 747-748.
10. + T and NK cells. J. Exp. Med. 180, 1937-1942.
11. KEHRL, J.H., WAKEHELD, L.M., ROBERTS, A.B., JAKOWLEW, S., ALVAREZ, M.M., DERYNCK, R., SPORN, M.B., and FAUCI, A.S. (1986). Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163, 1037-1050.
12. KEHRL, J.H., TAYLOR, A.S., DELSING, G.A., ROBERTS, A.B., SPORN, M.B., and FAUCI, A.S. (1989). Further studies of the role of transforming growth factor-beta in human B cell function. J. Immunol. 143, 1868-1874.
13. KIM, K.J., ABRAMS, J., ALPHONSO, M., PEARCE, M., THORBECKE, G.J., and PALLADINO, M.A. (1990). Role of endogenously produced interleukin-6 as a second signal in murine thymocyte proliferation induced by multiple cytokines: regulatory effects of transforming growth factor-beta. Cell. Immunol. 131, 261-271.
14. LEDBETTER, J.A., and HERZENBERG, L.A. (1979). Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47, 63-90.
15. LEFER, A.M., TSAO, P., AOKI, N., and PALLADINO, M.J. (1990). Mediation of cardioprotection by transforming growth factor-beta. Science 249, 61-64.
16. MULE, J.J., SCHWARZ, S.L., ROBERTS, A.B., SPORN, M.B., and ROSENBERG, S.A. (1988). Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer. Immunol. Immunother. 26, 95-100.
17. MUSTOE, T.A., PIERCE, G.F., THOMASON, A., GRAMATES, P., SPORN, M.B., and DEUEL, T.F. (1987). Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 237, 1333-1336.
18. OHARA, J., and PAUL, W.E. (1985). Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315, 333-336.
19. QIN, L., CHAVIN, K.D., DING, Y., WOODWARD, J.E., FAVARO, J.P., LIN, J., and BROMBERG, J.S. (1994). Gene therapy for transplantation: Prolongation of allograft survival with TGFβ1. Ann. Surg. 220, 508-519.
20. QIN, L., CHAVIN, K.D., DING, Y., FAVARRO, J.P., WOODWARD, J.E., LIN, J., TAHARA, H., ROBBINS, P.D., SHAKED, A., HO, D.Y., SAPOLSKY, R.M., LOTZE, M.T., and BROMBERG, J.S. (1995). Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model: Immunosuppression with TGF-β1 or vIL-10. Transplantation 59, 809-816.
21. QIN, L., CHAVIN, K.D., DING, Y., TAHARA, H., FAVARO, J.P., WOODWARD, J.E., SUZUKI, T., ROBBINS, P.D., LOTZE, M.T., and BROMBERG, J.S. (1996). Retrovirus-mediated transfer of viral interleukin-10 gene prolongs murine cardiac allograft survival. J. Immunol. 156, 2316-2323.
22. RANGES, G.E., FIGARI, I.S., ESPEVIK, T., and PALLADINO, M.J. (1987). Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 166, 991-998.
23. ROOK, A.H., KEHRL, J.H., WAKEFIELD, L.M., ROBERTS, A.B., SPORN, M.B., BURLINGTON, D.B., LANE, H.C., and FAUCI, A.S. (1986). Effects of transforming growth factor beta on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136, 3916-3920.
24. SATO, Y., ROMAM, M., TIGHE, H., LEE, D., CORR, M., NGUYEN, M., SILVERMAN, G.J., LOTZ, M., CARSON, D.A., and RAZ, E. (1996). Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352-354.
25. + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur. J. Immunol. 24, 793-798.
26. STAVNEZER, J. (1995). Regulation of antibody production and class switching by TGF-beta. J. Immunol. 155, 1647-1651.
27. TAKEUCHI, T., LOWRY, R.P., and KONIECZNY, B. (1992). Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 53, 1281-1294.
28. TASWELL, C. (1981). Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126, 1614-1619.
29. TORRE-AMIONE, G., BEAUCHAMP, R.D., KOEPPEN, H., PARK, B.H., SCHREIBER, H., MOSES, H.L., and ROWLEY, D.A. (1990). A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA 87, 1486-1490.
30. WALLICK, S.C., FIGARI, I.S., MORRIS, R.E. LEVINSON, A.D., and PALLADINO, M.A. (1990). Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1. J. Exp. Med. 172, 1777-1784.
31. WARWICK-DAVIES, J., LOWRIE, D.B., and COLE, P.J. (1995). Selective deactivation of human monocyte functions by TGF-beta. J. Immunol. 155, 3186-3193.
32. WOLFF, J.A., MALONE, R.W., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
33. ZHANG, X., GIANGRECO, L., BROOME, H.E., DARGAN, C.M., and SWAIN, S.L. 91995). Control of CD4 effector fate: Transforming growth factor beta 1 and interleukin 2 synergize to prevent apoptosis and promote effector expansion. J. Exp. Med. 182, 699-709.